Literature DB >> 18615859

Diabetes classification: grey zones, sound and smoke: Action LADA 1.

R D G Leslie1, H Kolb, N C Schloot, R Buzzetti, D Mauricio, A De Leiva, K Yderstraede, C Sarti, C Thivolet, D Hadden, S Hunter, G Schernthaner, W Scherbaum, R Williams, P Pozzilli.   

Abstract

Diseases gain identity from clinical phenotype as well as genetic and environmental aetiology. The definition of type 1 diabetes is clinically exclusive, comprising patients who are considered insulin dependent at diagnosis, whilst the definition of type 2 diabetes is inclusive, only excluding those who are initially insulin dependent. Ketosis-prone diabetes (KPD) and latent autoimmune diabetes in adults (LADA) are each exclusive forms of diabetes which are, at least initially, clinically distinct from type 2 diabetes and type 1 diabetes, and each have a different natural history from these major types of diabetes.KPD can be diagnosed unequivocally as diabetes presenting with the categorical clinical feature, ketoacidosis. In contrast, LADA can be diagnosed by the co-occurrence of three traits, not one of which is categorical or exclusive to the condition: adult-onset non-insulin-requiring diabetes, an islet autoantibody such as glutamic acid decarboxylase autoantibodies (GADA) or cytoplasmic islet cell autoantibodies (ICA), and no need for insulin treatment for several months post-diagnosis. But while some would split diabetes into distinct subtypes, there is a strong case that these subtypes form a continuum of varying severity of immune and metabolic dysfunction modified by genetic and non-genetic factors. This article discusses the nature of disease classification in general, and KPD and LADA in particular, emphasizing the potential value and pitfalls in classifying diabetes and suggesting a need for more research in this area. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18615859     DOI: 10.1002/dmrr.877

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  43 in total

Review 1.  The pathogenesis and natural history of type 1 diabetes.

Authors:  Mark A Atkinson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 2.  Vaccination against type 1 diabetes.

Authors:  H E Larsson; Å Lernmark
Journal:  J Intern Med       Date:  2011-06       Impact factor: 8.989

3.  Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.

Authors:  M N Pham; M I Hawa; C Pfleger; M Roden; G Schernthaner; P Pozzilli; R Buzzetti; W A Scherbaum; W Scherbaum; J Seissler; H Kolb; S Hunter; R D G Leslie; N C Schloot
Journal:  Diabetologia       Date:  2011-02-24       Impact factor: 10.122

4.  Latent autoimmune diabetes of adults is phenotypically similar to type 1 diabetes in a minority population.

Authors:  Kristina Djekic; Aram Mouzeyan; Eli Ipp
Journal:  J Clin Endocrinol Metab       Date:  2011-12-28       Impact factor: 5.958

5.  Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.

Authors:  Chao Deng; Yufei Xiang; Tingting Tan; Zhihui Ren; Chuqing Cao; Gan Huang; Li Wen; Zhiguang Zhou
Journal:  Diabetes Care       Date:  2015-12-30       Impact factor: 19.112

Review 6.  Diabetes mellitus: The epidemic of the century.

Authors:  Akram T Kharroubi; Hisham M Darwish
Journal:  World J Diabetes       Date:  2015-06-25

7.  The emerging global epidemic of type 1 diabetes.

Authors:  Jaakko Tuomilehto
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

Review 8.  Genetics of type 1 diabetes.

Authors:  Maria J Redondo; Andrea K Steck; Alberto Pugliese
Journal:  Pediatr Diabetes       Date:  2017-11-02       Impact factor: 4.866

Review 9.  Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection.

Authors:  Yu Liao; Yufei Xiang; Zhiguang Zhou
Journal:  Front Med       Date:  2012-07-28       Impact factor: 4.592

Review 10.  Beta-cell protection and therapy for latent autoimmune diabetes in adults.

Authors:  Simona Cernea; Raffaella Buzzetti; Paolo Pozzilli
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.